Monday, November 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Samsung Biologics closes tender offer for PolyPeptide Group, with 98% of shares tendered

Samsung Biologics closes tender offer for PolyPeptide Group, with 98% of shares

TR
By Tom Reyes · Markets Editor
Nov 2 03:04 ETSource: 머니투데이

From the source

Samsung Biologics closes tender offer for PolyPeptide Group, with 98% of shares tendered

Samsung Biologics closes tender offer for PolyPeptide Group, with 98% of shares tendered

Read at mt.co.kr
PeptiPrescribed peptides from $99/moSee all →